Refining the Use and Sequencing of Third-Line Therapy in Patients With Metastatic Colorectal Cancer

被引：0
作者：
Grothey, Axel [1 ]
机构：
[1] OneOncology, GI Canc Res, West Canc Ctr, Germantown, TN 38138 USA
来源：
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY | 2020年 / 18卷 / 01期
关键词：
CLINICAL-PRACTICE; ASIAN PATIENTS; DOUBLE-BLIND; REGORAFENIB; MONOTHERAPY; TAS-102; TRIAL;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：7 / 14
页数：8
相关论文
共 14 条
[1]  
[Anonymous], 2017, STIVARGA
[2]  
[Anonymous], 2015, J CLIN ONCOL S
[3]   Safety and effectiveness of regorafenib in patients with metastatic colorectal cancer in routine clinical practice in the prospective, observational CORRELATE study [J].
Ducreux, Michel ;
Petersen, Lone Norgard ;
Oehler, Leopold ;
Bergamo, Francesca ;
Metges, Jean-Philippe ;
de Groot, Jan Willem ;
Wang, Jaw-Yuan ;
Garcia Paredes, Beatriz ;
Dochy, Emmanuelle ;
Fiala-Buskies, Sabine ;
Cervantes, Andres ;
Manuel O'Connor, Juan ;
Falcone, Alfredo .
EUROPEAN JOURNAL OF CANCER, 2019, 123 :146-154
[4]   Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trial [J].
Eng, Cathy ;
Kim, Tae Won ;
Bendel, Johanna ;
Argiles, Guillem ;
Tebbutt, Niofi C. ;
Di Bartolomeo, Mafia ;
Falcone, Alfredo ;
Fakih, Marwan ;
Kozloff, Mark ;
Segal, Neil H. ;
Sobrero, Alberto ;
Yan, Yibing ;
Chang, Llsung ;
Uyei, Anne ;
Roberts, Louise ;
Ciardieffo, Fortunato .
LANCET ONCOLOGY, 2019, 20 (06) :849-861
[5]  
Falcone A, 2018, ANN ONCOL, V29
[6]   Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial [J].
Grothey, Axel ;
Van Cutsem, Eric ;
Sobrero, Alberto ;
Siena, Salvatore ;
Falcone, Alfredo ;
Ychou, Marc ;
Humblet, Yves ;
Bouche, Olivier ;
Mineur, Laurent ;
Barone, Carlo ;
Adenis, Antoine ;
Tabernero, Josep ;
Yoshino, Takayuki ;
Lenz, Heinz-Josef ;
Goldberg, Richard M. ;
Sargent, Daniel J. ;
Cihon, Frank ;
Cupit, Lisa ;
Wagner, Andrea ;
Laurent, Dirk .
LANCET, 2013, 381 (9863) :303-312
[7]   Phase Ib study of atezolizumab combined with cobimetinib in patients with solid tumors [J].
Hellmann, M. D. ;
Kim, T-W ;
Lee, C. B. ;
Goh, B-C ;
Miller, W. H., Jr. ;
Oh, D-Y ;
Jamal, R. ;
Chee, C-E ;
Chow, L. Q. M. ;
Gainor, J. F. ;
Desai, J. ;
Solomon, B. J. ;
Das Thakur, M. ;
Pitcher, B. ;
Foster, P. ;
Hernandez, G. ;
Wongchenko, M. J. ;
Cha, E. ;
Bang, Y-J ;
Siu, L. L. ;
Bendell, J. .
ANNALS OF ONCOLOGY, 2019, 30 (07) :1134-1142
[8]   Regorafenib in the Real-Life Clinical Practice: Data from the Czech Registry [J].
Kopeckova, Katerina ;
Buchler, Tomas ;
Bortlicek, Zbynek ;
Hejduk, Karel ;
Chloupkova, Renata ;
Melichar, Bohuslav ;
Pokorna, Petra ;
Tomasek, Jiri ;
Linke, Zdenek ;
Petruzelka, Lubos ;
Kiss, Igor ;
Prausova, Jana .
TARGETED ONCOLOGY, 2017, 12 (01) :89-95
[9]   Regorafenib plus best supportive care versus placebo plus best supportive care in Asian patients with previously treated metastatic colorectal cancer (CONCUR): a randomised, double-blind, placebo-controlled, phase 3 trial [J].
Li, Jin ;
Qin, Shukui ;
Xu, Ruihua ;
Yau, Thomas C. C. ;
Ma, Brigette ;
Pan, Hongming ;
Xu, Jianming ;
Bai, Yuxian ;
Chi, Yihebali ;
Wang, Liwei ;
Yeh, Kun-Huei ;
Bi, Feng ;
Cheng, Ying ;
Le, Anh Tuan ;
Lin, Jen-Kou ;
Liu, Tianshu ;
Ma, Dong ;
Kappeler, Christian ;
Kalmus, Joachim ;
Kim, Tae Won .
LANCET ONCOLOGY, 2015, 16 (06) :619-629
[10]   Randomized Trial of TAS-102 for Refractory Metastatic Colorectal Cancer [J].
Mayer, Robert J. ;
Van Cutsem, Eric ;
Falcone, Alfredo ;
Yoshino, Takayuki ;
Garcia-Carbonero, Rocio ;
Mizunuma, Nobuyuki ;
Yamazaki, Kentaro ;
Shimada, Yasuhiro ;
Tabernero, Josep ;
Komatsu, Yoshito ;
Sobrero, Alberto ;
Boucher, Eveline ;
Peeters, Marc ;
Tran, Ben ;
Lenz, Heinz-Josef ;
Zaniboni, Alberto ;
Hochster, Howard ;
Cleary, James M. ;
Prenen, Hans ;
Benedetti, Fabio ;
Mizuguchi, Hirokazu ;
Makris, Lukas ;
Ito, Masanobu ;
Ohtsu, Atsushi .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (20) :1909-1919
12